A retrospective study to investigate the prognostic value of Prognostic Nutritional Index on pembrolizumab treatment outcomes in Metastatic Urothelial Carcinoma patients
Latest Information Update: 06 Apr 2021
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 06 Apr 2021 New trial record
- 01 Mar 2021 Results published in the Anticancer Research